CorMedix Common Stock vs Current Deferred Revenue Analysis

CRMD Stock  USD 9.53  0.35  3.81%   
CorMedix financial indicator trend analysis is way more than just evaluating CorMedix prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether CorMedix is a good investment. Please check the relationship between CorMedix Common Stock and its Current Deferred Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CorMedix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For information on how to trade CorMedix Stock refer to our How to Trade CorMedix Stock guide.

Common Stock vs Current Deferred Revenue

Common Stock vs Current Deferred Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of CorMedix Common Stock account and Current Deferred Revenue. At this time, the significance of the direction appears to have almost no relationship.
The correlation between CorMedix's Common Stock and Current Deferred Revenue is 0.19. Overlapping area represents the amount of variation of Common Stock that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of CorMedix, assuming nothing else is changed. The correlation between historical values of CorMedix's Common Stock and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock of CorMedix are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Common Stock i.e., CorMedix's Common Stock and Current Deferred Revenue go up and down completely randomly.

Correlation Coefficient

0.19
Relationship DirectionPositive 
Relationship StrengthInsignificant

Common Stock

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.
Most indicators from CorMedix's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into CorMedix current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CorMedix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For information on how to trade CorMedix Stock refer to our How to Trade CorMedix Stock guide.At present, CorMedix's Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 155.8 M, whereas Sales General And Administrative To Revenue is forecasted to decline to 20.53.
 2021 2022 2023 2024 (projected)
Depreciation And Amortization177.0K209.0K70.8K79.6K
Research Development13.1M10.7M13.2M10.2M

CorMedix fundamental ratios Correlations

0.750.480.810.940.20.610.240.260.92-0.52-0.140.93-0.93-0.930.91-0.151.00.210.960.930.931.0-0.28-0.26-0.15
0.750.680.850.680.280.410.550.610.72-0.34-0.160.66-0.64-0.880.640.050.740.560.840.540.670.75-0.22-0.260.09
0.480.680.620.410.080.080.820.240.540.230.060.48-0.26-0.490.550.380.470.190.530.360.490.480.55-0.28-0.04
0.810.850.620.68-0.090.390.430.50.83-0.320.190.77-0.64-0.80.750.150.80.440.820.730.790.81-0.24-0.210.06
0.940.680.410.680.420.60.260.30.88-0.54-0.40.94-0.98-0.920.92-0.270.950.260.940.880.920.94-0.27-0.25-0.05
0.20.280.08-0.090.420.240.290.340.06-0.23-0.820.14-0.38-0.370.13-0.320.220.360.30.010.110.21-0.08-0.190.31
0.610.410.080.390.60.240.060.360.42-0.28-0.160.43-0.64-0.590.39-0.590.610.330.50.580.410.62-0.39-0.13-0.04
0.240.550.820.430.260.290.060.460.30.38-0.120.27-0.12-0.340.330.350.240.420.330.10.270.240.490.040.46
0.260.610.240.50.30.340.360.460.18-0.01-0.340.18-0.3-0.480.13-0.020.260.990.330.070.170.27-0.37-0.210.47
0.920.720.540.830.880.060.420.30.18-0.5-0.070.97-0.85-0.890.97-0.060.920.110.950.940.980.92-0.18-0.18-0.12
-0.52-0.340.23-0.32-0.54-0.23-0.280.38-0.01-0.50.22-0.510.640.55-0.440.37-0.520.01-0.58-0.5-0.51-0.520.70.170.17
-0.14-0.160.060.19-0.4-0.82-0.16-0.12-0.34-0.070.22-0.190.40.33-0.170.27-0.16-0.36-0.230.0-0.16-0.140.140.15-0.16
0.930.660.480.770.940.140.430.270.180.97-0.51-0.19-0.91-0.880.99-0.060.930.110.940.941.00.93-0.19-0.19-0.11
-0.93-0.64-0.26-0.64-0.98-0.38-0.64-0.12-0.3-0.850.640.4-0.910.92-0.870.34-0.93-0.25-0.92-0.88-0.9-0.930.420.220.07
-0.93-0.88-0.49-0.8-0.92-0.37-0.59-0.34-0.48-0.890.550.33-0.880.92-0.850.16-0.93-0.42-0.98-0.81-0.88-0.930.360.280.02
0.910.640.550.750.920.130.390.330.130.97-0.44-0.170.99-0.87-0.850.00.910.070.920.930.990.91-0.07-0.2-0.13
-0.150.050.380.15-0.27-0.32-0.590.35-0.02-0.060.370.27-0.060.340.160.0-0.15-0.04-0.11-0.22-0.02-0.150.40.00.02
1.00.740.470.80.950.220.610.240.260.92-0.52-0.160.93-0.93-0.930.91-0.150.210.960.930.931.0-0.27-0.27-0.15
0.210.560.190.440.260.360.330.420.990.110.01-0.360.11-0.25-0.420.07-0.040.210.270.010.110.21-0.38-0.20.49
0.960.840.530.820.940.30.50.330.330.95-0.58-0.230.94-0.92-0.980.92-0.110.960.270.870.940.95-0.28-0.24-0.06
0.930.540.360.730.880.010.580.10.070.94-0.50.00.94-0.88-0.810.93-0.220.930.010.870.940.93-0.24-0.17-0.19
0.930.670.490.790.920.110.410.270.170.98-0.51-0.161.0-0.9-0.880.99-0.020.930.110.940.940.93-0.18-0.18-0.12
1.00.750.480.810.940.210.620.240.270.92-0.52-0.140.93-0.93-0.930.91-0.151.00.210.950.930.93-0.28-0.27-0.15
-0.28-0.220.55-0.24-0.27-0.08-0.390.49-0.37-0.180.70.14-0.190.420.36-0.070.4-0.27-0.38-0.28-0.24-0.18-0.28-0.08-0.15
-0.26-0.26-0.28-0.21-0.25-0.19-0.130.04-0.21-0.180.170.15-0.190.220.28-0.20.0-0.27-0.2-0.24-0.17-0.18-0.27-0.080.61
-0.150.09-0.040.06-0.050.31-0.040.460.47-0.120.17-0.16-0.110.070.02-0.130.02-0.150.49-0.06-0.19-0.12-0.15-0.150.61
Click cells to compare fundamentals

CorMedix Account Relationship Matchups

CorMedix fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets29.5M49.3M68.9M62.0M82.1M86.2M
Other Current Liab4.8M2.9M3.0M4.0M7.0M7.3M
Total Current Liabilities5.8M4.2M5.3M6.3M11.4M12.0M
Accounts Payable1.0M1.1M2.2M2.2M4.3M4.5M
Cash16.5M42.1M53.6M43.4M43.6M45.8M
Other Current Assets501.2K1.7M954.0K758.8K1.3M725.0K
Total Liab5.8M5.1M6.1M7.0M11.9M7.3M
Common Stock25.7K33.6K38.1K42.8K54.9K36.3K
Property Plant Equipment126.8K1.1M1.5M2.4M2.7M2.9M
Short Long Term Debt Total2.7K1.0M923.8K802.4K667.6K634.3K
Total Stockholder Equity(195.4M)(217.4M)(245.7M)(275.4M)70.1M73.6M
Property Plant And Equipment Net126.8K1.1M2.4M2.4M2.5M2.6M
Net Debt(16.5M)(41.1M)(52.6M)(42.6M)(43.0M)(40.8M)
Retained Earnings(195.4M)(217.4M)(245.7M)(275.4M)(321.7M)(305.6M)
Non Current Assets Total126.8K1.1M2.5M2.5M2.6M2.7M
Non Currrent Assets Other126.8K(1.1M)102.3K102.3K103.1K108.2K
Cash And Short Term Investments28.5M46.5M65.7M59.0M76.0M79.8M
Common Stock Total Equity108.9K25.7K33.6K38.1K43.8K36.2K
Common Stock Shares Outstanding24.2M28.6M37.7M40.3M50.9M53.4M
Liabilities And Stockholders Equity(189.6M)(212.4M)(239.5M)(268.4M)82.1M86.2M
Other Stockholder Equity(123.2K)261.5M308.3M330.3M391.7M411.3M
Property Plant And Equipment Gross126.8K1.1M2.7M2.8M3.0M3.2M
Total Current Assets29.3M48.2M66.5M59.6M79.5M83.4M
Accumulated Other Comprehensive Income97.3K102.0K87.1K82.7K94.1K56.5K
Non Current Liabilities Total2.7K923.7K802.4K667.6K517.0K491.2K
Net Tangible Assets23.6M44.2M62.8M55.1M63.3M66.5M
Net Receivables64.1K10.9K35.03.4K45.4K0.0
Retained Earnings Total Equity(179.0M)(195.4M)(217.4M)(245.7M)(221.1M)(210.0M)
Short Term Investments12.0M4.4M12.1M15.6M32.4M34.0M
Capital Surpluse183.7M218.9M261.5M308.3M354.6M372.3M
Inventory428.5K338.5K143.6K3.0K2.1M2.2M
Net Invested Capital23.6M44.2M62.8M55.1M70.1M43.1M
Net Working Capital23.5M44.0M61.1M53.2M68.0M42.1M
Capital Stock25.9K33.8K38.3K43.0K55.1K40.7K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether CorMedix is a strong investment it is important to analyze CorMedix's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CorMedix's future performance. For an informed investment choice regarding CorMedix Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CorMedix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For information on how to trade CorMedix Stock refer to our How to Trade CorMedix Stock guide.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CorMedix. If investors know CorMedix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CorMedix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.80)
Revenue Per Share
0.212
Quarterly Revenue Growth
(0.47)
Return On Assets
(0.38)
Return On Equity
(0.65)
The market value of CorMedix is measured differently than its book value, which is the value of CorMedix that is recorded on the company's balance sheet. Investors also form their own opinion of CorMedix's value that differs from its market value or its book value, called intrinsic value, which is CorMedix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CorMedix's market value can be influenced by many factors that don't directly affect CorMedix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CorMedix's value and its price as these two are different measures arrived at by different means. Investors typically determine if CorMedix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CorMedix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.